Yang; Zhenfan
Patent Applications and Registrations
Patent applications and USPTO patent grants for Yang; Zhenfan.The latest application filed is for "dna-dependent protein kinase inhibitor".
- Yang; Zhenfan - Shanghai CN
| Patent | Date |
|---|---|
| ERBB receptor inhibitors Grant 11,447,492 - Li , et al. September 20, 2 | 2022-09-20 |
| Dna-dependent Protein Kinase Inhibitor App 20220242884 - QI; Changhe ; et al. | 2022-08-04 |
| Jak1 Selective Kinase Inhibitor App 20220220096 - QI; Changhe ; et al. | 2022-07-14 |
| Erbb/btk Inhibitors App 20210252005 - LI; Zhengtao ; et al. | 2021-08-19 |
| Pyrazine Compounds And Uses Thereof App 20210251989 - QI; Changhe ; et al. | 2021-08-19 |
| ErbB/BTK inhibitors Grant 11,007,198 - Li , et al. May 18, 2 | 2021-05-18 |
| Pyrazine compounds and uses thereof Grant 10,898,481 - Qi , et al. January 26, 2 | 2021-01-26 |
| Triazolo-pyrimidine Compounds And Uses Thereof App 20210009600 - ZENG; Qingbei ; et al. | 2021-01-14 |
| Erbb Receptor Inhibitors App 20210009587 - LI; Zhengtao ; et al. | 2021-01-14 |
| Triazolo-pyrimidine compounds and uses thereof Grant 10,858,365 - Zeng , et al. December 8, 2 | 2020-12-08 |
| ErbB receptor inhibitors Grant 10,822,334 - Li , et al. November 3, 2 | 2020-11-03 |
| Triazolo-pyrimidine Compounds And Uses Thereof App 20200331918 - ZENG; Qingbei ; et al. | 2020-10-22 |
| Pyrazine Compounds And Uses Thereof App 20200330458 - QI; Changhe ; et al. | 2020-10-22 |
| Erbb Receptor Inhibitors App 20200317669 - LI; Zhengtao ; et al. | 2020-10-08 |
| Erbb/btk Inhibitors App 20200316079 - LI; Zhengtao ; et al. | 2020-10-08 |
| Quinazoline Inhibitors Of Activating Mutant Forms Of Epidermal Growth Factor Receptor App 20180016259 - Li; David Yunzhi ; et al. | 2018-01-18 |
| Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor Grant 9,718,806 - Li , et al. August 1, 2 | 2017-08-01 |
| Quinazoline Inhibitors Of Activating Mutant Forms Of Epidermal Growth Factor Receptor App 20160340342 - LI; David Yunzhi ; et al. | 2016-11-24 |
| Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor Grant 9,375,432 - Li , et al. June 28, 2 | 2016-06-28 |
| Quinazoline Inhibitors of activating mutant forms of Epidermal Growth Factor Receptor App 20150320751 - Li; David Yunzhi ; et al. | 2015-11-12 |
| Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor Grant 9,066,979 - Li , et al. June 30, 2 | 2015-06-30 |
| Quinazoline Inhibitors of activating mutant forms of Epidermal Growth Factor Receptor App 20140255428 - LI; David Yunzhi ; et al. | 2014-09-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 